Article Sidebar

PDF (Tiếng Việt)
Published: 2023-12-15
Abstract Views: 117
Views PDF (Tiếng Việt): 216
DOI: https://doi.org/10.52852/tcncyh.v171i10.2009
Issue
Vol. 171 No. 10 (2023)
Section
Các bài báo
How to Cite
Phúc, Đỗ G. ., Thành, N. T. ., & Hải, H. B. . (2023). 43. Case series report: High-risk pulmonary embolism with contraindications of thrombolytic therapy at Hanoi Medical University Hospital. Journal of Medical Research, 171(10), 374-381. https://doi.org/10.52852/tcncyh.v171i10.2009

43. Case series report: High-risk pulmonary embolism with contraindications of thrombolytic therapy at Hanoi Medical University Hospital

Do Giang Phuc, Nguyen Tat Thanh, Hoang Bui Hai

Main Article Content

Abstract

Thrombolytic therapy has proven effective and safe in the treatment of high-risk pulmonary embolism. In the case of patients who have contraindications to thrombolytics, it is truly a clinical challenge in treatment. The early and accurate use of unfractionated heparin, preparation of the intervention, and pulmonary embolectomy team combined with multidisciplinary consultation (The Pulmonary Embolism Response Team) is the optimal strategy nowadays.

Article Details

Keywords

Acute pulmonary embolism, thrombolytic, unfractionated heparin, pulmonary embolectomy

References

1. Konstantinides SV, Meyer G, Becattinin C, et al. 2019 ESC Guideline for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology. European Heart Journal. 2020;41:543-603.
2. Tapson VF. Acute Pulmonary Embolism. N Engl J Med. 2008;358:1037-1092.
3. Longo DL, Kasper DL, Jameson JL, et al. Deep venous thrombosis and pulmonary thromnoembolism: Introduction. Harrison’principles of internal medicine. Section 2, chapter 262. McGraw-Hill company. 2012;1(11).
4. Hoàng Bùi Hải, Đỗ Giang Phúc, Lê Duy Lạc, và cs. Bước đầu điều trị bằng Alteplase liều thấp cho bệnh nhân tắc động mạch phổi cấp có ngừng tuần hoàn. Tạp chí Nghiên cứu Y học. 2020;134(10):1-7.
5. Hai HB, Phuc DG, Lac LD, et al. Safety, Efficacy of an Accelerated Regimen of Low Dose Recombinant Tissue-type Plasminogen Activator for Reperfusion Therapy of Acute Pulmonary Embolism. Clinical and Applied Thrombosis/Hemostasis. Clin Appl Thromb Hemost. 2021;27:10760296211037920.
6. Kearon C, Akl EA, Comerota AJ. Antithrombotic Therapy for VTE Disease. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2):e419S-e494S.
7. Trịnh Thị Thu Hiền, Nguyễn Quang Tùng, Hoàng Bùi Hải. Điều trị tắc động mạch phổi cấp bằng heparin không phân đoạn theo aPTT đích. Tạp chí Nghiên cứu Y học. 2017;105(1):130-6.
8. Dudzinski DM, Piazza G. Multidisciplinary Pulmonary Embolism Response Teams. Circulation. 2016;133:98.